Clostridioides difficile Detection in a Human CRC Cohort
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background The role of the gut microbiome and specific enteric bacteria in influencing the development of colorectal cancer (CRC) remains incompletely understood. Recently, it was shown that human CRC-derived strains of Clostridioides difficile were capable of inducing colonic tumorigenesis in a susceptible mouse model. We hypothesized that C. difficile contributes to the pathogenesis of human CRC and would be enriched in CRC tumors compared to paired normal tissues from the same individual. Methods We analyzed matched tumor/normal tissue samples from a cohort of 108 individuals presenting to a tertiary care hospital in Kuala Lumpur, Malaysia, for CRC resection between 2013 and 2014. We assessed the prevalence of C. difficile detection using 16S rRNA amplicon sequencing with high-resolution taxonomic assignment as well as culture and PCR. Results We found that detection of C. difficile was prevalent (38% of individuals), but of low abundance (tumor median relative abundance 0.01%, paired normal 0.006% [P = .4]). Detection of C. difficile was more prevalent in individuals with biofilm-positive tumor tissues than biofilm-negative (ie, 81% of C. difficile–positive individuals were biofilm-positive vs 63% of C. difficile–negative individuals [P = .04]). Additionally, in exploratory analyses, we describe patterns of taxonomic and inferred functional pathway differences between C. difficile–positive and C. difficile–negative groups. Conclusions These findings suggest that C. difficile is frequently present in low abundance in the tumor microbiome with a potentially significant impact on community composition and function.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofag169
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,053
Funders: Burroughs Wellcome Fund, Institute of International Education, Center for Alternatives to Animal Testing, Johns Hopkins Bloomberg School of Public Health, University of Maryland, Baltimore County, Johns Hopkins University, University of Maryland, Brain Science Institute, Johns Hopkins University, Emerald Foundation, Biocodex Microbiota Foundation, Cancer Research UK, Universiti Malaya, Norges Idrettshøgskole, National Institutes of Health, Sidney Kimmel Comprehensive Cancer Center, Biomedical Research and Environmental Sciences Division, Beatson Institute for Cancer Research, Instituto Nacional do Câncer, Ministério da Saúde, National Cancer Institute, National Institute of General Medical Sciences, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Awards: G1032176113, G1165598027, G1577313406, G1610190245, G1716268017, G2670884154, G3190913938, G3205903500, G3318661017, G3572430074, G3674872835, G465951118, Biofilm Epidemiology and Mechanisms in Colon Cancer, G5793141334, G6445951524, G6743030886, G7316241620, G770599991, G7725588249, G8522080923, G9000041231, G9000066787, G9000149319, G9000321810
OpenAlex ID: W7142361548
